Found 17 matching trials
Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia in Complete Remission PHASE1 RATIONALE: Vaccines made from dendritic cells may help the body build an ef...
Show More Location
Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes
Learn More & Join Trial
Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology PHASE1 The goal of this clinical trial is to to evaluate the safety and efficacy o...
Show More Learn More & Join Trial
Relmacabtagene Autoleucel as First-Line Therapy for High-Risk Large B-Cell Lymphoma PHASE2 The primary objective of this study is to estimate the efficacy of Relmacab...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Study to Evaluate the Safety and Efficacy of ARI0002h, for the Initial Treatment of Patients With Primary Plasma Cell Leukaemia PHASE2 Phase II, pilot, open-label, prospective, multicenter, non-randomized study...
Show More Location
Hospital Marqués de Valdecilla
Learn More & Join Trial
Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R PHASE2 RATIONALE: Giving chemotherapy before an autologous stem cell transplant st...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of HY004 Treatment in Adult Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r B-ALL) PHASE1 This is a multi-center, phase I/II trial to evaluate the safety and efficac...
Show More Location
Multiple Locations
Learn More & Join Trial
Clinical Trial Using Humanized CART Directed Against BCMA (ARI0002h) in Patients With Relapsed/Refractory Multiple Myeloma to Proteasome Inhibitors, Immunomodulators and Anti-CD38 Antibody. PHASE1 To assess the safety and efficacy of CARTBCMA ARI0002h in patients with rel...
Show More Location
Hospital U. de Santiago de Compostela
Learn More & Join Trial
Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant PHASE2 RATIONALE: Giving chemotherapy, such as busulfan and fludarabine phosphate,...
Show More Location
Tunnell Cancer Center at Beebe Medical Center
Learn More & Join Trial
An Exploratory Clinical Trial of Autologous Humanized Anti-cluster of Differentiation Antigen 19/20(CD19/CD20) Dual Specific CAR-T Cells Injection PHASE1 This is a single-arm, open-label, dose escalation, phase I study, aiming to...
Show More Location
First Affiliated Hospital of Zhejiang University
Learn More & Join Trial
A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma PHASE1 This is a Phase 1b/2, multicenter, open-label, study of JNJ-90014496, an au...
Show More Status
Active Not Recruiting
Learn More & Join Trial